Clinical trial
Randomized Controlled Trial of Lasmiditan Over Four Migraine Attacks
NCT03670810 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Trial of Lasmiditan Over Four Migraine Attacks
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 24, 2019
- Completion date
- July 8, 2021
- Enrollment
- 1,633 (actual)
- Sites
- 141
Conditions
As the registry lists them; a condition with its own page is linked.
migraine